Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.

Cancer research | Mar 15, 2003

http://www.ncbi.nlm.nih.gov/pubmed/12649204

In women, >80% of malignant ovarian tumors are of epithelial origin. Early detection of these tumors is very challenging,and extensive i.p. dissemination is common by the time of diagnosis. The lack of adequate geneticmouse models of ovarian carcinomas significantly delays advances in early detection and treatment. We report that female transgenic mice expressing the transforming region of SV40 under control of the Mullerian inhibitory substance type II receptor gene promoter develop bilateral ovarian tumors in approximately 50% of cases. Histologically, these tumors are poorly differentiated carcinomas with occasional cysts and papillary structures present at the surface of the ovary. These tumors disseminate i.p., invade omentum, and form ascites as do human ovarian carcinomas. The epithelial origin of these tumors is supported by detection of cytokeratins 8 and 19, and the absence of alpha-inhibin, a protein characteristically expressed in normal granulosa cells and most granulosa cell tumors. Cell lines derived from the ascites exhibit the properties of epithelial ovarian cancer, such as anchorage-independent growth, tumorigenicity in immunocompromised mice, expression of epithelial cell markers, and organotropic implantation. The availability of a transgenic mouse model of disseminated ovarian carcinoma and respective cell lines should advance our understanding of this neoplasm, and serve as a useful tool for the evaluation of emerging detection and treatment strategies.

Pubmed ID: 12649204 RIS Download

Mesh terms: Animals | Antigens, Polyomavirus Transforming | Chimera | Disease Models, Animal | Epithelium | Female | Humans | Immunohistochemistry | Mice | Mice, Inbred C57BL | Mice, Transgenic | Ovarian Neoplasms | Pregnancy | Promoter Regions, Genetic | Receptors, Peptide | Receptors, Transforming Growth Factor beta | Regulatory Sequences, Nucleic Acid | Reverse Transcriptase Polymerase Chain Reaction | Transfection | Tumor Cells, Cultured

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA06927
  • Agency: NCI NIH HHS, Id: CA51228
  • Agency: NCI NIH HHS, Id: CA56916
  • Agency: NCI NIH HHS, Id: CA83638
  • Agency: NCI NIH HHS, Id: CA84241
  • Agency: NCI NIH HHS, Id: CA84242
  • Agency: NCI NIH HHS, Id: CA96823

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.